Actemra® (tocilizumab) – New indication
December 21, 2022 - Genentech announced the FDA approval of Actemra (tocilizumab) intravenous infusion, for treatment of hospitalized adult patients with coronavirus disease 2019 (COVID-19) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Top